Heart Failure
Sequence, timing of HF, diabetes, psychosis have ‘complex’ effect on long-term mortality
Adults who developed diabetes, psychosis and congestive HF, in that order, had reduced life expectancy compared with people who developed the same three conditions in a different order, researchers reported.
Anthracyclines for breast cancer, lymphoma linked to higher congestive heart failure risk
Treatment with anthracyclines for breast cancer or lymphoma correlated with more than two times higher risk for congestive heart failure than that of healthy controls, according to a study conducted at Mayo Clinic.
Outcomes after HF hospitalization suboptimal, perhaps due to failure to follow guidelines
Among more than 250,000 patients hospitalized for HF for the first time in four countries, more than one-quarter died within 1 year of their hospitalization, according to the EVOLUTION HF cohort study.
Meta-analysis confirms benefits of SGLT2 inhibitors in various high-risk populations
SGLT2 inhibitors reduce risk for CV death and HF events in patients with any or multiple of HF, type 2 diabetes and chronic kidney disease, according to a meta-analysis published in the Journal of the American College of Cardiology.
Valve repair helps in HF, severe mitral regurgitation, even in patients with malnutrition
In patients with HF and severe secondary mitral regurgitation, transcatheter edge-to-edge mitral valve repair reduced mortality and HF hospitalization regardless of whether patients had malnutrition, new data from the COAPT trial show.
Female sexual dysfunction with heart failure ‘underrecognized and undertreated’
Female sexual dysfunction among women with HF is inconsistently assessed in studies, with researchers using a variety of questionnaires that do not capture the breadth of symptoms, which may limit proper treatment, data show.
Risk for heart failure in women after pregnancy underrecognized
PHILADELPHIA — Hypertensive disorders of pregnancy significantly increase risk for HF in women during pregnancy and later in life, yet many women never receive adequate preconception counseling or follow-up care, according to a speaker.
Top in cardiology: Iron injection for heart failure; ANNEXA phase IV trial stopped
The FDA has approved the first-ever IV iron replacement therapy to improve exercise capacity in adults with heart failure.
Medicaid beneficiaries with diabetes, HF often do not receive best care after discharge
Among Medicaid beneficiaries with diabetes and heart failure in Alabama, many did not have a follow-up visit within 14 days of hospitalization in accordance with guidelines, researchers reported.
VIDEO: SGLT2 inhibition helpful for managing residual cardiometabolic risk
In this Healio | Cardiology Today video exclusive, Chad Morreale, DO, discusses his presentation at the National Lipid Association Scientific Sessions: “Cardiometabolic Disease Patient – How Do I Approach Residual Risk?”